Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States. The study results, published in Annals of Internal Medicine, could help researchers evaluate how the prescription patterns of GLP-1RAs have […]
